[
  {
    "title": "STAT+: Nature Medicine to investigate  study that found cancer treatment is better in morning",
    "link": "https://www.statnews.com/2026/02/20/cancer-immunotherapy-morning-infusions-doubts-about-study/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-21T01:13:11.000Z",
    "summary": "Nature Medicine starts an investigation into inconsistencies in a study that found it was better to have immunotherapy in the morning."
  },
  {
    "title": "STAT+: DOJ, Ohio attorney general accuse OhioHealth of driving up prices, crowding out competition",
    "link": "https://www.statnews.com/2026/02/20/doj-ohio-antitrust-lawsuit-ohiohealth-acontracts/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-20T21:17:59.000Z",
    "summary": "Regulators say Ohio hospital system made it difficult for health insurers to offer cheaper plans."
  },
  {
    "title": "Grail’s multi-cancer early detection test misses study goal",
    "link": "https://www.biopharmadive.com/news/grails-multi-cancer-early-detection-test-misses-study-goal/812744/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-20T19:16:43.000Z",
    "summary": "Shares in the company lost about half their value in Friday trading after use of the test wasn’t associated with a statistically significant reduction in late-stage cancer diagnoses."
  },
  {
    "title": "Supreme Court invalidates Trump tariffs based on emergency powers",
    "link": "https://www.biopharmadive.com/news/supreme-court-invalidates-trump-tariffs-based-on-emergency-powers/812723/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-20T18:57:00.000Z",
    "summary": "In a 6-3 decision, the court rejected President Trump's claim that a 1977 law gave him the authority to impose broad tariffs globally."
  },
  {
    "title": "Roche gets FDA decision date on closely watched breast cancer drug",
    "link": "https://www.biopharmadive.com/news/roche-giredestrant-serd-fda-approval-decision-breast-cancer/812695/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-20T17:16:22.000Z",
    "summary": "The agency could by late December approve a therapy that Roche sees as potentially becoming a new treatment standard for certain breast tumors."
  },
  {
    "title": "Madrigal sees a stock sell-off; ex-Novartis exec heads to Daiichi",
    "link": "https://www.biopharmadive.com/news/madrigal-earnings-daiichi-tsai-acimmune-alzheimers-novartis-unnatural/812565/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-20T15:23:00.000Z",
    "summary": "Madrigal shares fell 11% despite again topping consensus sales numbers. Elsewhere, Daiichi Sankyo named a new research chief and J&J halted recruitment in an Alzheimer’s trial."
  },
  {
    "title": "STAT+: Up and down the ladder: The latest comings and goings",
    "link": "https://www.statnews.com/pharmalot/2026/02/20/pharma-biotech-jobs-roche-sanofi-daiichi/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-20T14:52:46.000Z",
    "summary": "From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry."
  },
  {
    "title": "STAT+: Element Biosciences launches table-top sequencer capable of $100 genome",
    "link": "https://www.statnews.com/2026/02/20/biotech-news-element-biosciences-100-dollar-genome/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-20T14:32:31.000Z",
    "summary": "And other biotech news brought to you by The Readout newsletter"
  },
  {
    "title": "STAT+: Pharmalittle: We’re reading about an FDA official’s speech, a Grail cancer blood test, and much more",
    "link": "https://www.statnews.com/pharmalot/2026/02/20/fda-cancer-antibiotics-kickbacks-otc-patents-covid/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-20T14:26:16.000Z",
    "summary": "The FDA's top drug regulator indicated in her first address to staff that she will scrutinize antidepressants and shots used to protect babies from RSV"
  },
  {
    "title": "ACIP meeting postponed, for reasons that are unclear",
    "link": "https://www.statnews.com/2026/02/20/health-news-acip-meeting-postponed-covid-19/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-20T12:55:15.000Z",
    "summary": "And other health news from today's Morning Rounds newsletter"
  },
  {
    "title": "AI is slashing jobs across industries. Will pharma be next?",
    "link": "https://www.biopharmadive.com/news/ai-biotech-pharma-jobs-layoffs-amazon-nvidia-pharma/812635/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-20T11:28:00.000Z",
    "summary": "Despite a wave of AI-fueled layoffs, the pharma and biotech industries could be spared from massive cutbacks for now."
  },
  {
    "title": "With federal research funding uncertain, states debate new science initiatives",
    "link": "https://www.statnews.com/2026/02/20/states-fill-nih-funding-gap-trump-cuts/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-20T09:30:00.000Z",
    "summary": "A handful of states are considering initiatives to increase funding for scientific research as uncertainty around federal dollars has grown."
  },
  {
    "title": "Biohackers and wellness influencers are pushing nicotine as part of their ‘stacks’",
    "link": "https://www.statnews.com/2026/02/20/nicotine-wellness-startups-productivity-boost-legal-gray-area/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-20T09:30:00.000Z",
    "summary": "As smoking rates fall in the U.S., startups and influencers are pushing the purported cognitive and health benefits of indulging in nicotine."
  },
  {
    "title": "Would you trust AI to renew your drug prescriptions?",
    "link": "https://www.statnews.com/2026/02/20/doctronic-ai-physician-chatbot-explored-alex-hogan-status-report/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-20T09:30:00.000Z",
    "summary": "Would you trust AI to renew your drug prescriptions? Alex Hogan explores the question on this week's episode of STATus Report."
  },
  {
    "title": "Opinion: On ‘The Pitt,’ art catches up with the medical debt crisis",
    "link": "https://www.statnews.com/2026/02/20/tv-show-the-pitt-highlights-medical-debt-crisis/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-20T09:30:00.000Z",
    "summary": "Joe Sachs, a physician and executive producer on “The Pitt,” and the CEO of Undue Medical Debt weigh in on the show’s foray into a health care crisis."
  },
  {
    "title": "Opinion: STAT+: Sometimes, it would be unethical not to use AI in medicine",
    "link": "https://www.statnews.com/2026/02/20/ai-medical-ethics-doctors-unethical-not-use-ai/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-20T09:30:00.000Z",
    "summary": "“We do not let pilots fly without instrument support simply because they technically could. Why should medicine be different?”"
  },
  {
    "title": "STAT+: Texas attorney general sues Sanofi for allegedly providing kickbacks to doctors to prescribe its drugs",
    "link": "https://www.statnews.com/pharmalot/2026/02/19/sanofi-nurses-kickbacks-texas-paxton-insurance/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-20T02:04:27.000Z",
    "summary": "The Texas AG has filed a lawsuit accusing Sanofi of providing kickbacks to doctors, in the form of a free network of nurses and insurance support services."
  },
  {
    "title": "Clearing cholesterol combats secondary lymphoedema",
    "link": "https://www.nature.com/articles/d41573-026-00032-6",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-20T00:00:00.000Z",
    "summary": ""
  },
  {
    "title": "The pancreatic cancer drug market",
    "link": "https://www.nature.com/articles/d41573-026-00027-3",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-20T00:00:00.000Z",
    "summary": ""
  },
  {
    "title": "STAT+: Key study of Grail’s cancer detection test fails in setback for company",
    "link": "https://www.statnews.com/2026/02/19/grail-cancer-test-galleri-results/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T22:38:45.000Z",
    "summary": "Grail's blood test for detecting cancer early failed to meet its main goal in a giant study being conducted with England’s NHS, the company said."
  },
  {
    "title": "STAT+: In first speech to her FDA staff, Høeg says she’ll scrutinize RSV shots and SSRIs in pregnancy",
    "link": "https://www.statnews.com/2026/02/19/tracy-beth-hoeg-fda-speech-to-staff-ssris-in-pregnancy-rsv-shots/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T21:42:55.000Z",
    "summary": "The top drug regulator at the FDA told staff she plans to question the safety of taking SSRIs in pregnancy and of RSV shots given to infants."
  },
  {
    "title": "Hims’ Super Bowl fallout, and the FDA reverses course",
    "link": "https://www.statnews.com/2026/02/19/hims-super-bowl-ad-moderna-fda-readout-loud/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T20:54:32.000Z",
    "summary": "Was Hims' Super Bowl ad the final straw for regulators? Is the bar being lowered for psychedelic medicines? And what's happening with Moderna and FDA? Find out on \"The Readout…"
  },
  {
    "title": "STAT+: FDA taps AI executive to lead digital health center",
    "link": "https://www.statnews.com/2026/02/19/fda-appoints-new-digital-health-center-director/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T20:32:53.000Z",
    "summary": "FDA has tapped a former executive from a health AI company to lead its digital health center."
  },
  {
    "title": "STAT+: The federal directory of doctors and hospitals is coming this year",
    "link": "https://www.statnews.com/2026/02/19/cms-national-provider-directory-launch-beta-test/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T19:35:05.000Z",
    "summary": "Patients have long had to navigate error-prone lists of doctors and hospitals."
  },
  {
    "title": "STAT+: 5 powerful people to know at HHS",
    "link": "https://www.statnews.com/2026/02/19/powerful-people-at-hhs-oz-talks-with-pharma-dc-diagnosis-newsletter/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T17:13:14.000Z",
    "summary": "Find out who's on the rise inside RFK Jr.'s federal health department."
  },
  {
    "title": "Altesa, run by former Trump official, raises $75M for well-traveled lung drug",
    "link": "https://www.biopharmadive.com/news/Altesa-biotech-startup-financing-giroir-vapendavir-copd-lung/812566/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-19T17:06:00.000Z",
    "summary": "Led by Brett Giroir and GSK’s ex-chief medical officer, Altesa is advancing a medicine that’s changed hands multiple times and once failed a study in asthma."
  },
  {
    "title": "FDA leaders say one pivotal trial, not two, should be ‘default’ for drug approvals",
    "link": "https://www.biopharmadive.com/news/fda-makary-prasad0one-pivotal-trial-nejm/812557/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-19T16:20:00.000Z",
    "summary": "In a NEJM article, Commissioner Martin Makary and top deputy Vinay Prasad argued that the new policy should lower development costs and speed development without compromising agency standards."
  },
  {
    "title": "STAT+: AI-guided cancer treatments, telehealth usage, and other health tech news",
    "link": "https://www.statnews.com/2026/02/19/ai-guided-cancer-treatment-telehealth-usage-health-tech/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T14:25:49.000Z",
    "summary": "In this edition of STAT Health Tech: A new wave of AI-guided cancer treatments, a Hims acquisition, and other health tech news."
  },
  {
    "title": "STAT+: Pharmalittle: We’re reading about the FDA pushing OTC meds, its new trial standards, and much more",
    "link": "https://www.statnews.com/pharmalot/2026/02/19/fda-otc-trials-jnj-novo-obesity-antibiotics-hims-hiv/?utm_campaign=rss",
    "source": "STAT News",
    "category": "industry",
    "date": "2026-02-19T14:08:32.000Z",
    "summary": "FDA Commissioner Marty Makary said he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring"
  },
  {
    "title": "Lilly to pay CSL $100M to license monoclonal antibody targeting IL-6",
    "link": "https://www.biopharmadive.com/news/lilly-deal-csl-100m-license-monoclonal-antibody-targeting-il-6/812455/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-18T16:15:18.000Z",
    "summary": "The Australian company will retain rights for an end-stage kidney disease indication currently being tested in a Phase 3 trial while Lilly explores other uses."
  },
  {
    "title": "FDA accepts BMS protein degrader for review; Disc rare disease drug rejected",
    "link": "https://www.biopharmadive.com/news/disc-news-roundup-pharma-biotech/812351/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-18T15:35:17.000Z",
    "summary": "Cytokinetics’ heart disease drug secured European approval. Elsewhere, Teva and Sanofi reported longer-term data from an experimental therapy targeting ulcerative colitis and Crohn’s disease."
  },
  {
    "title": "An Alzheimer’s startup emerges with $175M in venture backing",
    "link": "https://www.biopharmadive.com/news/korsana-alzheimers-amyloid-beta-plaque-launch/812443/",
    "source": "BioPharma Dive",
    "category": "industry",
    "date": "2026-02-18T15:22:54.000Z",
    "summary": "Backed by Wellington, Sanofi Ventures and a division of J.P. Morgan, Korsana Therapeutics is studying a treatment originally developed by hub-and-spoke biotech Paragon Therapeutics."
  },
  {
    "title": "PIP4K2C: an emerging fulcrum for multiple diseases",
    "link": "https://www.nature.com/articles/d41573-026-00030-8",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-18T00:00:00.000Z",
    "summary": ""
  },
  {
    "title": "Therapeutic targeting of neuroimmune mechanisms in neurodegeneration",
    "link": "https://www.nature.com/articles/s41573-025-01370-7",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-16T00:00:00.000Z",
    "summary": ""
  },
  {
    "title": "TIGIT’s immuno-oncology teachings",
    "link": "https://www.nature.com/articles/d41573-026-00031-7",
    "source": "Nature Reviews Drug Discovery",
    "category": "research",
    "date": "2026-02-16T00:00:00.000Z",
    "summary": ""
  }
]
